Our research is made possible by the generous support of the following agencies and foundations.
Research Council of Norway (Norges Forskningsråd) FRIPRO Young Talent, 2026–2030
The Research Council of Norway is the primary funding agency for research across all disciplines in Norway, supporting projects that advance knowledge and contribute to innovation and societal development. The CONVERGE project — "Decoding Developmental Convergence: Mapping Genetic Risk Across Neural and Cardiac Lineages" — is funded through the FRIPRO Young Talent scheme, which supports outstanding early-career researchers in establishing independent research programmes. (10M NOK / ~1M USD)
European Commission — Marie Skłodowska-Curie Actions Horizon Europe, Individual Global Fellowship, 2022–2025
The Marie Skłodowska-Curie Actions fund researchers at all career stages and encourage transnational, cross-sector, and interdisciplinary mobility. My project — "Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons" — was supported through a Global Fellowship enabling research at Yale University and Haukeland University Hospital. (€307K / ~300K USD)
Brain & Behavior Research Foundation (BBRF/NARSAD) Young Investigator Grant, 2026–2027
The Brain & Behavior Research Foundation is the largest private funder of mental health research grants in the United States, awarding Young Investigator Grants to support the most promising early-career neuroscience and psychiatry researchers worldwide. Our project — "Decoding Glutamatergic Dysfunction in Treatment-Resistant Schizophrenia: CRISPR Dissection of High-Risk Variants and Clozapine's Pathway-Specific Rescue" — is funded through this programme. (70K USD)
Helse Vest RHF Postdoctoral Fellowship, 2025–2027
Helse Vest RHF (Western Norway Regional Health Authority) funds health research to strengthen evidence-based practice and improve patient care across western Norway's hospital system. Our postdoctoral fellowship supports research at Haukeland University Hospital within the Division of Psychiatry. (NOK 3.2M / ~300K USD)
Trond Mohn Research Foundation (TMS) Through the Mohn Research Centre for Regenerative Medicine (MRCRM), 2021–2027
The Trond Mohn Research Foundation supports excellent research environments in Norway, with a focus on long-term investments that strengthen research capacity and infrastructure. Our stem cell-based disease modelling work in the Division of Psychiatry at Haukeland operates within the MRCRM, a strategic initiative between Haukeland University Hospital and the University of Bergen established with TMS support. (NOK 8M/ ~800K USD)
National Institutes of Health (NIH/NIMH) Through collaborative multi-centre projects
The National Institute of Mental Health is the lead US federal agency for research on mental disorders. Our research has been supported through NIH-funded collaborative projects, including a multi-centre study on the functional convergence of neurodevelopmental disorder risk genes (R01) and the SSPsyGene Consortium — a national effort to characterise the neurobiology of 250 genes associated with psychiatric and neurodevelopmental disorders.